Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| JOHNSON & JOHNSON | 24,911 | reported | 01 May 2026 | tx 39+469,159−315,994 |
| Clovis Oncology, Inc. | 12,414 | reported | 14 Jun 2012 | tx 1+12,414 |
| COMMAND SECURITY CORP | 5,000 | reported | 27 May 2010 | tx 1+5,000 |
| ZONAGEN INC | 5,000 | reported | 20 May 2009 | tx 6+153,846 |
| STRATAGENE CORP | 0 | reported | 06 Jun 2007 | tx 5+30,000−40,000 |
| PHARMION CORP | 0 | reported | 07 Mar 2008 | tx 5+15,000−40,000 |
| IONIS PHARMACEUTICALS INC | 0 | reported | 06 Sept 2012 | tx 20+127,500−60,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | EXERCISE | JOHNSON & JOHNSON | 25,255 | 0.00 USD | |
| 01 May 2026 | TAX_WITHHOLDING | JOHNSON & JOHNSON | 11,002 | 229.85 USD | |
| 01 May 2026 | EXERCISE | JOHNSON & JOHNSON | 25,255 | 0.00 USD | deriv |
| 17 Feb 2026 | EXERCISE | JOHNSON & JOHNSON | 29,927 | 156.15 USD | |
| 17 Feb 2026 | SALE | JOHNSON & JOHNSON | 29,927 | 243.00 USD | |
| 17 Feb 2026 | SALE | JOHNSON & JOHNSON | 2,283 | 243.00 USD | |
| 15 Feb 2026 | EXERCISE | JOHNSON & JOHNSON | 1,349 | 0.00 USD | |
| 17 Feb 2026 | SALE | JOHNSON & JOHNSON | 21,721 | 243.00 USD | |
| 15 Feb 2026 | EXERCISE | JOHNSON & JOHNSON | 1,847 | 0.00 USD | |
| 15 Feb 2026 | TAX_WITHHOLDING | JOHNSON & JOHNSON | 528 | 243.45 USD | |
| 17 Feb 2026 | EXERCISE | JOHNSON & JOHNSON | 21,721 | 157.92 USD | |
| 15 Feb 2026 | TAX_WITHHOLDING | JOHNSON & JOHNSON | 385 | 243.45 USD | |
| 17 Feb 2026 | EXERCISE | JOHNSON & JOHNSON | 21,721 | 0.00 USD | deriv |
| 15 Feb 2026 | GRANT_AWARD | JOHNSON & JOHNSON | 3,546 | 0.00 USD | deriv |
| 15 Feb 2026 | GRANT_AWARD | JOHNSON & JOHNSON | 49,382 | 0.00 USD | deriv |
| 15 Feb 2026 | EXERCISE | JOHNSON & JOHNSON | 1,847 | 0.00 USD | deriv |
| 15 Feb 2026 | EXERCISE | JOHNSON & JOHNSON | 1,349 | 0.00 USD | deriv |
| 17 Feb 2026 | EXERCISE | JOHNSON & JOHNSON | 29,927 | 0.00 USD | deriv |
| 17 Oct 2025 | EXERCISE | JOHNSON & JOHNSON | 21,721 | 157.92 USD | |
| 17 Oct 2025 | SALE | JOHNSON & JOHNSON | 21,721 | 192.71 USD | |
| 17 Oct 2025 | EXERCISE | JOHNSON & JOHNSON | 21,721 | 157.92 USD | deriv |
| 17 Jul 2025 | SALE | JOHNSON & JOHNSON | 19,137 | 163.55 USD | |
| 01 May 2025 | EXERCISE | JOHNSON & JOHNSON | 25,255 | 0.00 USD | |
| 01 May 2025 | TAX_WITHHOLDING | JOHNSON & JOHNSON | 11,002 | 156.31 USD | |
| 01 May 2025 | EXERCISE | JOHNSON & JOHNSON | 25,255 | 0.00 USD | deriv |